Publication | Closed Access
SHMT2 is Associated with Tumor Purity, CD8+ T Immune CellsInfiltration, and a Novel Therapeutic Target in Four DifferentHuman Cancers
33
Citations
26
References
2022
Year
Our results suggested that overexpressed SHMT2 is correlated with the reduced OS and RFS of the BRCA, KIRP, LIHC, and LUAD patients and can be a potential diagnostic and prognostic biomarker for these cancers.
| Year | Citations | |
|---|---|---|
Page 1
Page 1